These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 20171144)
1. Lacosamide intoxication in attempted suicide. Bauer S; David Rudd G; Mylius V; Hamer HM; Rosenow F Epilepsy Behav; 2010 Apr; 17(4):549-51. PubMed ID: 20171144 [TBL] [Abstract][Full Text] [Related]
2. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain. Harris JA; Murphy JA Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834 [TBL] [Abstract][Full Text] [Related]
3. Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures. Krauss G; Ben-Menachem E; Mameniskiene R; Vaiciene-Magistris N; Brock M; Whitesides JG; Johnson ME; Epilepsia; 2010 Jun; 51(6):951-7. PubMed ID: 20041945 [TBL] [Abstract][Full Text] [Related]
4. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures. Beydoun A; D'Souza J; Hebert D; Doty P Expert Rev Neurother; 2009 Jan; 9(1):33-42. PubMed ID: 19102666 [TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures. Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895 [TBL] [Abstract][Full Text] [Related]
6. Minimizing pharmacodynamic interactions of high doses of lacosamide. Edwards HB; Cole AG; Griffiths AS; Lin B; Bean A; Krauss GL Acta Neurol Scand; 2012 Apr; 125(4):228-33. PubMed ID: 22070525 [TBL] [Abstract][Full Text] [Related]
7. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T; Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227 [TBL] [Abstract][Full Text] [Related]
8. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Tilz C; Resch R; Hofer T; Eggers C Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy. Gavatha M; Ioannou I; Papavasiliou AS Epilepsy Behav; 2011 Apr; 20(4):691-3. PubMed ID: 21406334 [TBL] [Abstract][Full Text] [Related]
12. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction? Novy J; Patsalos PN; Sander JW; Sisodiya SM Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937 [TBL] [Abstract][Full Text] [Related]
13. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report. Chua-Tuan JL; Cao D; Iwanicki JL; Hoyte CO Clin Toxicol (Phila); 2015 Jul; 53(6):565-8. PubMed ID: 25951877 [TBL] [Abstract][Full Text] [Related]
14. Preliminary efficacy and safety of lacosamide in children with refractory epilepsy. Heyman E; Lahat E; Levin N; Berkovitch M; Gandelman-Marton R Eur J Paediatr Neurol; 2012 Jan; 16(1):15-9. PubMed ID: 21924653 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with using lacosamide for the treatment of epilepsy in a tertiary centre. Kamel JT; DeGruyter MA; D'Souza WJ; Cook MJ Acta Neurol Scand; 2013 Mar; 127(3):149-53. PubMed ID: 22845761 [TBL] [Abstract][Full Text] [Related]
18. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats. Brandt C; Heile A; Potschka H; Stoehr T; Löscher W Epilepsia; 2006 Nov; 47(11):1803-9. PubMed ID: 17116018 [TBL] [Abstract][Full Text] [Related]
19. Lacosamide in pediatric and adult patients: comparison of efficacy and safety. Verrotti A; Loiacono G; Pizzolorusso A; Parisi P; Bruni O; Luchetti A; Zamponi N; Cappanera S; Grosso S; Kluger G; Janello C; Franzoni E; Elia M; Spalice A; Coppola G; Striano P; Pavone P; Savasta S; Viri M; Romeo A; Aloisi P; Gobbi G; Ferretti A; Cusmai R; Curatolo P Seizure; 2013 Apr; 22(3):210-6. PubMed ID: 23298605 [TBL] [Abstract][Full Text] [Related]
20. Early add-on lacosamide in a real-life setting: results of the REALLY study. Villanueva V; Garcés M; López-Gomáriz E; Serratosa JM; González-Giráldez B; Parra J; Rodríguez-Uranga J; Toledo M; López González FJ; Bermejo P; Giner P; Castillo A; Molins A; Campos D; Mauri JÁ; Muñoz R; Bonet M; Serrano-Castro P; del Villar A; Saiz-Díaz RA; Clin Drug Investig; 2015 Feb; 35(2):121-31. PubMed ID: 25488477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]